会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • Cephalosporin compound and pharmaceutical composition thereof
    • Cephalosporinverbindungen und sie enthaltende pharmazeutischePräparate。
    • EP0293771A2
    • 1988-12-07
    • EP88108456.0
    • 1988-05-27
    • Kyoto Pharmaceutical Industries, Ltd.
    • Nishizawa, SusumuMuro, HiroyukiKasai, MasayasuHatano, SatoruKamiya, Syouzi 202, Nakagawa Co.op 5Kakeya, NobuharuKitao, Kazuhiko
    • C07D501/20C07D277/20C07D285/08A61K31/545
    • C07D277/587C07D285/08Y02P20/55
    • Cephalosporin compounds represented by the general formula (I):
      wherein R 1 and R 5 independently represented a hydrogen atom or a protective group for an amino group; R 2 represents an alkyl group or a cycloalkyl group; R 3 represents a hydrogen atom, a lower alkenyl group, an alkanoyloxymethyl group, a carbamoyloxymethyl group, a heterocyclic thiomethyl group or a heterocyclic methyl group; R 4 represents a hydrogen atom or an ester residue; and X represents CH or a nitrogen atom and pharmacologically acceptable addition salts thereof, intermediate compounds used in the synthesis process of these compounds, production methods of these compounds and pharmaceutical compositions containing these compounds.
      Said compounds or addition salts thereof exhibit noticeable antibacterial activities even on Pseudomonas aeruginosa, on which known cephalosporin compounds do not exhibit antibacterial activities, and moreover, work well against ordinary Gram-positive bacteria and Gram-negative bacteria.
    • 由通式(I)表示的头孢菌素化合物:其中R 1和R 5独立地表示氢原子或氨基的保护基; R 2表示烷基或环烷基; R 3表示氢原子,低级烯基,烷酰氧基甲基,氨基甲酰氧基甲基,杂环硫代甲基或杂环甲基; R 4表示氢原子或酯残基; X表示CH或氮原子及其药学上可接受的加成盐,这些化合物的合成中使用的中间体化合物,这些化合物的制造方法以及含有这些化合物的药物组合物。 所述化合物或其加成盐即使在绿脓假单胞菌上也显示出显着的抗菌活性,其中已知的头孢菌素化合物不具有抗菌活性,而且对普通的革兰氏阳性菌和革兰氏阴性细菌有很好的效果。